CompoAtlas

Floradapt(TM) Baby Colic

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bifidobacterium longum subsp. longum

Source : KABPTM 042

0.5 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : Bifidobacterium longum subsp. longum - Cellule entière

0.5 Milliards d'UFCNot calculated
Pediococcus pentosaceus

Source : KABPTM 041

0.5 Milliards d'UFCNot calculated

Non-medicinal ingredients

Dextrose, Vitamine E, L-Cystéine, Citrate de sodium, Ascorbate de sodium, Dioxyde de silicium, Trehalose, Maltodextrine, D-Mannitol

PopulationAgeQuantity per servingFrequency
Enfants et nourrissonsminimum: 1 year ; maximum: 3 years5 Gouttes1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps improve colic symptoms relief in babies/infants such as crying, fussing, or irritability. Helps to reduce crying time and frequency in colicky baby. Benefit in colic symptom for both formula and breast-fed baby. Provides benefit in crying time and frequency in 7 days. Floradapt(TM) Baby Colic is clinically proven to help provide/improve colic symptoms relief in both, formula and/or breast-fed babies/infants with colic syndrome. Floradapt(TM) Baby Colic is clinically proven as an effective therapy to colic syndrome in both, formula and/or breast-fed babies/infants and consequently helps improve the quality of life of the parents. Reduction of the total crying time in infants with colic. Helps reduce total crying time in infants with colic. Improvement in colic symptoms, impacting positively in the infant comfort and consequently in the quality of life of the parents. May benefit infants with colic syndrome by reducing daily crying time. Helps reduce the duration of crying episodes in babies/infants by providing gut comfort and colic symptoms relief. Helps improve colic symptoms relief in babies/infants such as crying, fussing, or irritability.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Licence holder
Kaneka Americas Holding Inc, CA, USA
NPN or DIN-HM
80127842
Status
Active licence
Licence date
6 November 2023
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80127842

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line